"Proteomics applied to drug development for inflammatory diseases" by Jesús Mateos Martín
|
Luns
|
Martes
|
Mércores
|
Xoves
|
Venres
|
Sábado
|
Domingo
|
|---|---|---|---|---|---|---|
|
0 eventos,
|
0 eventos,
|
0 eventos,
|
0 eventos,
|
0 eventos,
|
0 eventos,
|
0 eventos,
|
|
0 eventos,
|
0 eventos,
|
1 evento,
"Proteomics applied to drug development for inflammatory diseases" by Jesús Mateos Martín |
0 eventos,
|
0 eventos,
|
0 eventos,
|
0 eventos,
|
|
0 eventos,
|
0 eventos,
|
0 eventos,
|
0 eventos,
|
0 eventos,
|
0 eventos,
|
0 eventos,
|
|
0 eventos,
|
0 eventos,
|
0 eventos,
|
0 eventos,
|
0 eventos,
|
0 eventos,
|
0 eventos,
|
|
0 eventos,
|
0 eventos,
|
1 evento,
“Current state of clinical biomarkers for early diagnosis of Alzheimer´s Disease” by Marta Aramburu |
0 eventos,
|
0 eventos,
|
0 eventos,
|
0 eventos,
|
|
0 eventos,
|
0 eventos,
|
1 evento,
“Nasasbiotech: Bridging the gap between laboratory and clinical setting” by Lorena Alonso Alconada “Prolonged breastfeeding protects from obesity by hypothalamic action of hepatic FGF21” by Raquel Pérez Lois |
0 eventos,
|
0 eventos,
|
0 eventos,
|
0 eventos,
|